ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

STX Shield Therapeutics Plc

2.05
0.00 (0.00%)
14 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Shield Therapeutics Plc LSE:STX London Ordinary Share GB00BYV81293 ORD 1.5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 2.05 2.00 2.10 2.10 2.05 2.05 690,953 14:55:25
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 4.47M -40.44M -0.0522 -0.39 15.9M
Shield Therapeutics Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker STX. The last closing price for Shield Therapeutics was 2.05p. Over the last year, Shield Therapeutics shares have traded in a share price range of 1.075p to 12.75p.

Shield Therapeutics currently has 775,429,360 shares in issue. The market capitalisation of Shield Therapeutics is £15.90 million. Shield Therapeutics has a price to earnings ratio (PE ratio) of -0.39.

Shield Therapeutics Share Discussion Threads

Showing 22551 to 22572 of 23400 messages
Chat Pages: Latest  912  911  910  909  908  907  906  905  904  903  902  901  Older
DateSubjectAuthorDiscuss
13/11/2023
10:16
Skots he was given 7M options to agree to stay until summer 2024. The implication is that he's leaving (or possibly retiring) at that point.
cyberbub
13/11/2023
10:12
Where does it say he's leaving or is that your view cyber?Bollitix, the CEO and CFO made decision together the last two years so I still don't understand why you've always ranted at the CEO and loved the CFO. They were a leadership team and both been part of diluting and raising cash (and our current misery, which is still mostly the fault of previous CEOs)The CFO might have jumped disagreeing with strategy, just left for other reasons or been pushed, but none of us know the true story
skcots48
12/11/2023
11:01
Wrong bolitix.The CEO seens likely to be leaving next year, and has 7M free options to cash in. He has 7 millions reasons to get the share price as high as possible!
cyberbub
11/11/2023
07:29
When you buy into this share you need to understand this CEO does not give a hoot about the share price He is all about drumming up cash to keep his environment running. I don't think that is a bad thing but the sensitivity of his donkey timing is painful. I think most of us had the chance to average down and new investors have a great punt at less than 6p going forward
bolitix
07/11/2023
12:07
Am back in with 100k bought at 6.14p.
Near enough to 6p for me to be confident we near the bottom support.
Time will tell.

hamhamham1
06/11/2023
07:43
Awww bless. Another loser who buys on the spikes, sells at the bottom, and then forever blames the management. Move on.
the imperialist
05/11/2023
13:13
6p to 12p
Then back to 12p.

Endless cash raises.

And the FD now leaving.

Is this share just a complete load of rubbish or am I missing anything?

smithie6
05/11/2023
12:24
Apologies for the off topic folks but as it's out of hours.
Devon, have you cast an eye over DEST ?

captain james t kirk
03/11/2023
16:00
13p is the technical level. Even if we're going to 5p, we go to 13p first.
the imperialist
03/11/2023
15:59
Not sure what you are 'whating' qipincha, but if you're referring to my post 13074 I'm saying I believe a move to 8p+ COULD be on the horizon very soon (now the sellers are exhausted) and if so it MAY happen fairly quickly as we have seen with previous moves from this level.
parob
03/11/2023
14:06
Market cap is currently just £47M. Should the Q3 results match expectations I'm half expecting an offer to come in whilst it's so cheap.
parob
03/11/2023
14:05
Here it comes.....

DYOR

the imperialist
03/11/2023
13:57
Not saying this is definitely going to happen but if you look back at the chart there have been several occasions when the share price has consolidated around the 6p level then out of nowhere has shot back to 8p (and beyond) in a matter of days. Company has never been so advanced and we are hopefully due a Q3 update soon, hence I've averaged down a touch today. Certainly no worries about funding at the mo, and the markets are starting to turn more bullish so hopefully STX will also benefit.
parob
02/11/2023
16:48
What's more rewarding I'm short 2 of your stocks Both red today While the FTSE is up over a 100 points !!
amaretto1
31/10/2023
21:33
Your VLS ? Very smart
amaretto1
31/10/2023
18:57
I'm not worried about the Rx numbers, I'm confident they will be rocketing. The problem is the GTN. We need to see that starting to climb significantly by the new year, to give confidence that they won't need any more money, or least not at the current share price.
cyberbub
31/10/2023
17:55
So end 4q22 22 people make 9249 sales so 1 person per Q was 420. So for 100 embedded staff by 3Q23 the forecasted 28,454 sales could be nearer the 42k sales to equal the 4q22 rate. I am not surprised the forecasted 4Q23 at 51,217 either.

Given the prescriber access went up nearly 4 fold then the 100k per Q rate they need to meet their YE24 prediction of 370-420k sales is easily within reach while their 550-600k sales for YE25 should be achievable.

bolitix
30/10/2023
16:17
Could be a fantastic update locked-in and ready to roll at 7am.
the imperialist
30/10/2023
16:03
Has that bleeding' cat escaped from the bag again?
rustyke1
30/10/2023
14:54
Follow the smart money.
the imperialist
30/10/2023
14:35
...looks like some have already seen it given the price action.
the imperialist
30/10/2023
13:43
Q3 update should be close now…
rhatton
Chat Pages: Latest  912  911  910  909  908  907  906  905  904  903  902  901  Older

Your Recent History

Delayed Upgrade Clock